vs
Brainsway Ltd.(BWAY)与泰利福(TFX)财务数据对比。点击上方公司名可切换其他公司
BrainsWay是一家跨国医疗器械企业,成立于2003年,在美国和耶路撒冷均设有办公机构。该公司主打开发搭载H线圈的深部经颅磁刺激医疗器械,为抑郁症、强迫症、烟瘾提供非侵入式治疗方案。
泰利福(Teleflex)总部位于美国宾夕法尼亚州韦恩,是专业医疗设备供应商,产品广泛应用于重症监护、外科手术等各类诊疗场景。公司年营收达24亿美元,在全球40个国家开展业务,员工总数超15000人。经过数年的收并购与业务剥离,公司于2011年完成业务调整,全面聚焦医疗设备制造领域。
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BWAY
TFX
| Q4 25 | — | $-401.9M | ||
| Q3 25 | — | $913.0M | ||
| Q2 25 | — | $780.9M | ||
| Q1 25 | — | $700.7M | ||
| Q4 24 | — | $795.4M | ||
| Q3 24 | — | $764.4M | ||
| Q2 24 | — | $749.7M | ||
| Q1 24 | — | $737.8M |
净利润
BWAY
TFX
| Q4 25 | — | $-714.3M | ||
| Q3 25 | — | $-408.9M | ||
| Q2 25 | — | $122.6M | ||
| Q1 25 | — | $95.0M | ||
| Q4 24 | — | $-136.7M | ||
| Q3 24 | — | $111.0M | ||
| Q2 24 | — | $80.0M | ||
| Q1 24 | — | $15.3M |
毛利率
BWAY
TFX
| Q4 25 | — | — | ||
| Q3 25 | — | 49.5% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 55.3% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.6% | ||
| Q1 24 | — | 56.4% |
营业利润率
BWAY
TFX
| Q4 25 | — | — | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | -13.9% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | -0.6% |
净利率
BWAY
TFX
| Q4 25 | — | 177.8% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | 14.5% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | 2.1% |
每股收益(稀释后)
BWAY
TFX
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | — | $-2.89 | ||
| Q3 24 | — | $2.36 | ||
| Q2 24 | — | $1.69 | ||
| Q1 24 | — | $0.32 |